Health-Related Quality of Life in Lenalidomide and Bortezomib Treated Patients with Relapsed/Refractory Multiple Myeloma

被引:0
|
作者
Kyriakou, Charalampia [1 ,2 ]
Murphy, Philip [3 ]
Petrucci, Maria Teresa [4 ]
Bacon, Pamela [5 ]
Lewis, Philip [6 ]
Gilet, Helene [7 ]
Arnould, Benoit [7 ]
Vande Broek, Isabelle [8 ]
Leleu, Xavier [9 ]
机构
[1] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
[2] Northwick Pk Hosp & Clin Res Ctr, Dept Haematol, London NW3 2QG, England
[3] Beaumont Hosp, Dublin 9, Ireland
[4] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
[5] Celgene Int Sarl, Boudry, Switzerland
[6] Celgene GmbH, Munich, Germany
[7] Mapi, Lyon, France
[8] Iridium Kankernetwerk, St Niklaas, Belgium
[9] Hop Claude Huriez, CHRU, Lille, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Total costs of therapy with lenalidomide or bortezomib in relapsed/refractory multiple myeloma (rrMM).
    Borrello, Ivan
    Binder, Gary
    Khan, Zeba M.
    Pashos, Chris L.
    Durie, Brian G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
    Richardson, Paul G.
    Xie, Wanling
    Jagannath, Sundar
    Jakubowiak, Andrzej
    Lonial, Sagar
    Raje, Noopur S.
    Alsina, Melissa
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Munshi, Nikhil C.
    Mazumder, Amitabha
    Vesole, David H.
    Kaufman, Jonathan L.
    Colson, Kathleen
    McKenney, Mary
    Lunde, Laura E.
    Feather, John
    Maglio, Michelle E.
    Warren, Diane
    Francis, Dixil
    Hideshima, Teru
    Knight, Robert
    Esseltine, Dixie-Lee
    Mitsiades, Constantine S.
    Weller, Edie
    Anderson, Kenneth C.
    [J]. BLOOD, 2014, 123 (10) : 1461 - 1469
  • [33] Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients
    Wisloff, F
    Gulbrandsen, N
    [J]. ACTA ONCOLOGICA, 2000, 39 (07) : 809 - 813
  • [34] Bortezomib in Relapsed/Refractory Multiple Myeloma
    Shen, Z.
    Wang, L.
    Yan, H.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S62 - S62
  • [35] Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone: Patient Reported Outcomes from GRIFFIN
    Silbermann, Rebecca
    Laubach, Jacob
    Kaufman, Jonathan L.
    Sborov, Douglas W.
    Reeves, Brandi
    Rodriguez, Cesar
    Chari, Ajai
    Costa, Luciano J.
    Anderson, Larry D.
    Nathwani, Nitya
    Shah, Nina
    Bumma, Naresh
    Holstein, Sarah A.
    Costello, Caitlin
    Jakubowiak, Andrzej
    Orlowski, Robert Z.
    Shain, Kenneth H.
    Cowan, Andrew J.
    Gries, Katharine S.
    Pei, Huiling
    Cortoos, Annelore
    Patel, Sharmila
    Lin, Thomas S.
    Richardson, Paul G.
    Usmani, Saad
    Voorhees, Peter M.
    [J]. BLOOD, 2022, 140 : 1146 - 1149
  • [36] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
    Shin, Junghoon
    Lee, Je-Jung
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Jeong-Ok
    Suh, Cheolwon
    Kim, Jin Seok
    Lee, Yoo Jin
    Yoon, Sung-Soo
    Jo, Jae-Cheol
    Lee, Ho Sup
    Bang, Soo-Mee
    Lee, Jeong-Ok
    Bang, Soo-Mee
    Lee, Je-Jung
    Kim, Kihyun
    Min, Chang-Ki
    Suh, Cheolwon
    Yoon, Dok Hyun
    Kim, Jin Seok
    Lee, Yoo Jin
    Moon, Joon Ho
    Yoon, Sung-Soo
    Kim, Inho
    Jo, Jae-Cheol
    Lee, Ho Sup
    Park, Seong Kyu
    Shin, Ho-Jin
    Kim, Min Kyoung
    Mun, Yeung-Chul
    Lee, Mark Hong
    Park, Yong
    Eom, Hyeon Seok
    Kim, Hyo Jung
    Im, Sung Nam
    Kim, Sung-Hyun
    Do, Young Rok
    Lee, Won Sik
    Cho, Su-Hee
    Yi, Jun Ho
    Lee, Jae Hoon
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 79 - 90
  • [37] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
    Junghoon Shin
    Je-Jung Lee
    Kihyun Kim
    Chang-Ki Min
    Jeong-Ok Lee
    Cheolwon Suh
    Jin Seok Kim
    Yoo Jin Lee
    Sung-Soo Yoon
    Jae-Cheol Jo
    Ho Sup Lee
    Soo-Mee Bang
    [J]. International Journal of Hematology, 2019, 109 : 79 - 90
  • [38] A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide
    Dimopoulos, Meletios A.
    Richardson, Paul G.
    Brandenburg, Nancy
    Yu, Zhinuan
    Weber, Donna M.
    Niesvizky, Ruben
    Morgan, Gareth J.
    [J]. BLOOD, 2012, 119 (12) : 2764 - 2767
  • [39] Our Experience of Using Lenalidomide, Bortezomib and Dexamethasone (RVD) Therapy in Patients with Relapsed/Refractory Multiple Myeloma
    Pogosyan, Gayane
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S340 - S341
  • [40] Incidence of secondary cancers in refractory or relapsed multiple myeloma treated with lenalidomide
    Guidez, Stephanie
    Leleu, Xavier
    [J]. HEMATOLOGIE, 2012, 18 (03): : 150 - 151